U.S. (NIH) halts test of Trump-touted hydroxychloroquine for COVID-19 patients
Source: Reuters
HEALTH NEWS JUNE 20, 2020 / 12:23 PM / UPDATED 9 HOURS AGO
U.S. halts test of Trump-touted hydroxychloroquine for COVID-19 patients
(Reuters) - The U.S. National Institutes of Health said on Saturday it has halted a clinical trial to evaluate the safety and effectiveness of the malaria drug hydroxychloroquine for the treatment of hospitalized COVID-19 patients.
The study found that hydroxychloroquine, which President Donald Trump has frequently touted a possible treatment, did not provide any benefit to the patients, even though it did no harm, NIH said in a statement.
Earlier this week, the World Health Organization said testing of hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after new data and studies showed no benefit.
The U.S. Food and Drug Administration revoked its emergency use authorization for hydroxychloroquine to treat COVID-19 on Monday.
-snip-
Read more:
https://www.reuters.com/article/us-health-coronavirus-usa-hydroxychloroq/u-s-halts-test-of-trump-touted-hydroxychloroquine-for-covid-19-patients-idUSKBN23R0OT